Summary by Moomoo AI
CHINA PHARMACEUTICAL HOLDINGS LIMITED (HEREINAFTER REFERRED TO AS “CHINESE MEDICINE”) ANNOUNCED ON 29 APRIL 2024 THAT, PURSUANT TO ARTICLES 2.07A AND 2.07B OF THE SECURITIES LISTING RULES OF THE HONG KONG UNIFIED STOCK EXCHANGE LIMITED, AS WELL AS THE PAPERLESS LISTING SYSTEM AND ELECTRONIC PUBLICATION COMPANY COMMUNICATIONS EFFECTIVE FROM 31 DECEMBER 2023, THE COMPANY The company's newsletter has been published electronically. The newsletter includes Board reports, annual accounts, audit reports, interim reports, meeting notices, listing documents, circulars and proxy forms, etc. The Company informs non-registered shareholders that the English and Chinese versions of all company communications will be available on the Company's website and on the Disclosable Website, in place of the printed copies. Non-registered shareholders who wish to receive company communications...Show More